Frieder Schaumburg

Further involvements

• 18/09/2023

  13:45 – 14:00 10 Min. 5 Min.

  • Vortrag
  • DKMDVV 002

  Nucleic acid amplification testing (NAAT) of Staphylococcus aureus in urine from patients with S. aureus bacteremia

   Progress in pathogen diagnostics (FG DKM/StAG DV/jDGHM)
• 19/09/2023

  15:15 – 15:30 10 Min. 5 Min.

  • Vortrag
  • DKMZOV 067

  Genotypic and phenotypic analysis of Staphylococcus borealis isolated from clinical specimens in a tertiary hospital in Germany

   Progress in pathogen diagnostics (FG DKM/StAG DV/jDGHM)
• 19/09/2023

  • Poster
  • IIP 264

  Host determinants for the spread of PVL-positive Staphylococcus aureus in Sub-Saharan Africa

   Infektionsimmunologie, Wirt-basierte Therapien, Impfstoffe (FG II)
• 19/09/2023

  • Poster
  • IIP 259

  C5a receptor antagonists protect human neutrophils from Staphylococcus aureus Panton-Valentine leukocidin

   Infektionsimmunologie, Wirt-basierte Therapien, Impfstoffe (FG II)
• 19/09/2023

  • Poster
  • PRHYP 303

  Assessing the resolution of antibiogram similarity in molecular transmission analysis of multidrug-resistant pathogen by utilizing cgMLST as the benchmark

   IPC and MDRO and nosocomial pathogens (FG PR HY/StAG Hyg)
• 19/09/2023

  • Poster
  • MSZOP 254

  Comparison of broth microdilution and agar diffusion for antimicrobial susceptibility testing of Dermabacter hominis Tim R. Blum¹, Dennis Knaack², Sören Schubert³, Uwe Groß⁴, Robin Köck⁵, Frieder Schaumburg¹

   Epidemiology and Antimicrobial Resistance of Zoonotic Pathogens (FG MS/FG ZO)
• 19/09/2023

  • Poster
  • MSZOP 255

  Time trends of skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus in Lambaréné, Gabon

   Epidemiology and Antimicrobial Resistance of Zoonotic Pathogens (FG MS/FG ZO)